Category: Workers Comp

505 posts found

HHS Publishes Opioid Tapering and Discontinuation Guideline

The guideline covers a wide range of relevant topics, including pain, dosing, dangerous co-prescribing, comorbidities, and more.

Shortly after California made strides on employee classification for gig economy jobs, New Jersey and New York have taken action.

The Society of Actuaries published a report that claims the economic burden of the opioid epidemic was $631 billion from 2015-2018.

Indicated for various gastrointestinal concerns, these recalls could impact certain workers’ comp patients.

PwC explores how social factors impact chronic health conditions.

This reclassification will entitle millions of workers to benefits previously withheld, including workers’ comp.

Join Healthesystems at booth #1922, at an educational presentation, or by taking our industry survey with Risk & Insurance.

NKTR-181 (loxicodegol) was to receive an approval decision by August 29th, but a reevaluation of opioid policy has resulted in a delay.

Healthesystems’ clinical leaders speak to mitigation strategies to reduce workplace injuries stemming from fatigue.

The utilization of opioids, compounds, and physician-dispensed medications have significantly decreased.

Proposed changes to who can grow and research marijuana will soon be available for public commentary.

An Oklahoma judge found the drug maker to be partially responsible for the harm of the opioid epidemic.

Healthesystems’ Chief Medical Officer explores trends impacting workers’ comp, including patient engagement, population health, and more.

Nine generic versions of Lyrica (pregabalin) have been approved for the treatment of five different medical conditions.

Sandy Shtab has been recognized for making significant contributions to the workers’ comp industry.

Prev 1 2 3 4 5 … 25 26 27 28 29 30 31 32 33 34 Next